Safety evaluation of cryoablation device ICS4 in cryoablation of lung tumors

Safety evaluation of cryoablation device ICS4 in cryoablation of lung tumors - Safety evaluation of cryoablation device ICS4

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006118

Enrollment

Registered

2011-08-05

Start date

2011-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung tumors

Interventions

Cryoablation for lung tumors

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 5.1.1. Clinical diagnosis of lung tumor. 5.1.2. Standard treatments such as resection, chemotherapy, or radiation are not indicated. 5.1.3. Performance status 0 to 2. 5.1.4. 20 years old or older. 5.1.5. Life expectancy more than 3 months. 5.1.6. Informed consent can be obtained.

Exclusion criteria

Exclusion criteria: 5.1.7. Coagulopathies. 5.1.8. Bleeding tendencies. 5.1.9. Uncontrolled infection. 5.1.10. Uncontrolled brain or medullary metastasis. 5.1.11. Unable to tolerate general anesthesia. 5.1.12. Difficulties in communication. 5.1.13. Excluded by the attending physician.

Design outcomes

Primary

Measure	Time frame
safety	—

Secondary

Measure	Time frame
efficacy	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026